Sigma Pharmaceuticals (Australia) Pty Ltd v Wyeth
Jurisdiction | Australia Federal only |
Neutral Citation | [2011] FCAFC 132,2011-1028 FCA A |
Date | 2011 |
Year | 2011 |
Court | Full Federal Court (Australia) |
-
- This document is available in original version only for vLex customers
View this document and try vLex for 7 days - TRY VLEX
- This document is available in original version only for vLex customers
9 cases
-
InterPharma Pty Ltd v Hospira, Inc (No 5)
...238 Sanofi-Aventis Australia Pty Ltd v Apotex Pty Ltd (No 3) [2011] FCA 846; 196 FCR 1 Sigma Pharmaceuticals (Australia) Pty Ltd v Wyeth [2011] FCAFC 132; 119 IPR 194 Streetworx Pty Ltd v Artcraft Urban Group Pty Ltd [2014] FCA 1366; 110 IPR 82 W R Grace & Co v Asahi Kasei Kogyo Kabushiki K......
-
Boehringer Ingelheim Animal Health USA Inc v Elanco New Zealand
...being a real and reasonably clear disclosure of the invention. In Sigma Pharmaceuticals (Australia) Pty Ltd v Wyeth (2011) 119 IPR 194; [2011] FCAFC 132, claims unlimited to a particular type of extended release formulation of venlafaxine hydrochloride were found to be directly contradicted......
-
Merck Sharp and Dohme Corporation v Wyeth LLC (No 3)
...138; 348 ALR 156 Sequenom, Inc. v Ariosa Diagnostics, Inc. [2019] FCA 1011; 143 IPR 24 Sigma Pharmaceuticals (Australia) Pty Ltd v Wyeth [2011] FCAFC 132; 119 IPR 194 SNF (Australia) Pty Limited v BASF Australia Ltd [2019] FCA 425; 140 IPR 276 Stefanovski v Digital Central Australia (Assets......
-
Mylan Health Pty Ltd v Sun Pharma ANZ Pty Ltd
...(1946) 63 RPC 113 Regeneron Pharmaceuticals Inc v Genentech Inc [2012] EWHC 657 (Pat) Sigma Pharmaceuticals (Australia) Pty Ltd v Wyeth [2011] FCAFC 132; (2011) 119 IPR 194 Warner-Lambert Company LLC v Apotex Pty Ltd (No 2) [2018] FCAFC 26; 129 IPR 205 Date of hearing: 5-7 February 2020 Dat......
Request a trial to view additional results